Amphastar Pharmaceuticals, Inc. is a rapidly growing bio-pharmaceutical company that specializes in the development, manufacturing, marketing, and sales of various generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company, which was founded in 1996 and is headquartered in Rancho Cucamonga, California, operates through two segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API). The company's vast range of products includes Primatene Mist, an over-the-counter epinephrine inhalation product, Enoxaparin, a low molecular weight heparin, Naloxone for opioid overdose, Glucagon for injection emergency kit, and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. Amphastar Pharmaceuticals also provides bovine-sourced hyaluronidase injection Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, emergency syringe products, morphine injection, and Lorazepam injection. Moreover, the company offers products such as Neostigmine methylsulfate injection, Isoproterenol hydrochloride injection, Ganirelix Acetate injection, and Vasopressin, which are widely used in hospitals, care facilities, alternate care sites, clinics, and doctors' offices. Amphastar Pharmaceuticals is committed to providing high-quality products that are safe, effective, and affordable. With a diverse product portfolio, the company is well-positioned to meet the increasing demand for pharmaceutical products in the healthcare industry.
Amphastar Pharmaceuticals's ticker is AMPH
The company's shares trade on the NASDAQ stock exchange
They are based in Rancho Cucamonga, California
There are 1001-5000 employees working at Amphastar Pharmaceuticals
It is amphastar.com
Amphastar Pharmaceuticals is in the Healthcare sector
Amphastar Pharmaceuticals is in the Drug Manufacturers - Other industry
The following five companies are Amphastar Pharmaceuticals's industry peers: